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Edited by Judit Ova´diAbstract The cellular ATP concentration was tested for its ef-
fect on fatty acid biosynthesis from glucose in hepatocytes. ATP
was manipulated by adding increasing concentrations of cyclo-
heximide, amytal, atractyloside, 2,4-dinitrophenol or adenosine.
A slight decrease in cellular ATP coincided with a stimulation of
fatty acid biosynthesis whereas a further lowering of cellular
ATP resulted in a gradual inhibition. Increasing the cellular
ATP level by titration with adenosine had the opposite eﬀect.
These results are in line with the suggestion that fatty acid bio-
synthesis from glucose is an energy-yielding process which is sti-
mulated by a moderate drop in cellular ATP.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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In the course of studies on the control of fatty acid biosynth-
esis in isolated rat-liver cells, we observed a stimulation of the
basal rate of this process by cycloheximide, a well-known inhi-
bitor of protein synthesis [1]. Cycloheximide was used in these
studies to discriminate between long-term eﬀects (i.e. changes
in the number of enzyme molecules) and short-term eﬀects
(i.e. changes in activity of a constant number of enzyme mole-
cules) of various hormones [2,3].
Apart from its eﬀect on protein synthesis, cycloheximide is
an inhibitor of energy transfer at site I of the mitochondrial re-
spiratory chain [4]. Various studies indicate that the eﬀects ob-
served upon exposure of cells or tissues to cycloheximide may
not be exclusively due to its eﬀect on the synthesis of protein
[5]. Since fatty acid biosynthesis is regarded as an energy-re-
quiring process, it was not clear why a block of oxidative phos-
phorylation would result in a stimulation of this process.
The stimulation of the rate of fatty acid biosynthesis by low
concentrations of cycloheximide may result from the eﬀect of
this compound on the cellular ATP concentration. This con-
sideration led us to explore the eﬀect of modulators of the cel-*Corresponding author.
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rate of fatty acid biosynthesis in isolated hepatocytes.2. Materials and methods
2.1. Materials
Collagenase (type I), components of the culture medium, cyclohexi-
mide and amytal were obtained from Sigma; [1-14C]acetate and 3H2O
from Amersham; adenosine, enzymes and biochemicals for ATP assay
from Roche; atractyloside from Calbiochem; 2,4-dinitrophenol from
BDH; all other reagents from Baker.
2.2. Methods
Male Wistar rats (200–250 g) were meal-fed a standard laboratory
chow and fasted overnight prior to use. Full details of the procedure
for cell isolation and culturing have been described earlier [6]. For
monitoring the rate of fatty acid biosynthesis 4 ml of cell suspension
were added to 60-mm dishes. After 4 h of plating, the medium and
loose cells were removed by aspiration and an identical volume of fresh
medium was added to the plated cells, together with the compounds
under investigation and 3H2O (10 mCi; ﬁnal spec. radioact. 45 lCi/
mmol) or [1-14C]acetate (2.5 lCi; ﬁnal spec. radioact. 0.96 mCi/mmol).
After an additional hour of incubation, reactions were terminated by
adding 1.0 ml of ice-cold 0.5 M KOH. The rate of fatty acid biosynth-
esis was determined by measuring the incorporation of label into fatty
acids [7]. Cellular ATP levels were measured in plates simultaneously
incubated (10 ml of cell suspension in 100-mm dishes) without radioac-
tivity, in which the cells were killed with 0.5 ml of ice-cold 0.6 M
HClO4 [8]. Cyclic AMP was determined according to the protein-bind-
ing assay of Gilman [9], using cAMP-assay kits from Amersham. The
protein content of plated cells was determined by the Lowry method
[10].
2.3. Presentation of data
Experiments were repeated at least three times, all incubations being
run in triplicate. The data in the ﬁgure and tables are means ± S.D.
from a representative experiment. Diﬀerences were considered statisti-
cally signiﬁcant at P < 0.05.3. Results
A number of compounds is known to aﬀect the cellular ATP
concentration in isolated hepatocytes and perfused liver, each
in its own speciﬁc way. Increasing concentrations of cyclohex-
imide progressively decreased the ATP level in cultures of rat
hepatocytes (Table 1). Amytal, an inhibitor of electron trans-
port at site I like cycloheximide [11] and an uncoupler at high
concentrations [12], mimicked the eﬀect of cycloheximide on
the concentration of ATP. Atractyloside, which inhibits trans-blished by Elsevier B.V. All rights reserved.
Table 1
The eﬀect of various compounds aﬀecting cellular energy metabolism
on the ATP concentration and on fatty acid biosynthesis in





None 16.22 ± 1.13 1.80 ± 0.11
Cycloheximide
50 14.97 ± 0.77 3.04 ± 0.24c
500 13.16 ± 0.65b 2.52 ± 0.18c
5000 9.28 ± 0.97b 1.04 ± 0.12c
Amytal
0.1 15.33 ± 0.55 2.51 ± 0.21c
5 14.00 ± 0.77a 2.61 ± 0.19c
10 12.96 ± 0.84b 2.42 ± 0.17c
1000 9.00 ± 0.94c 0.84 ± 0.09d
Atractyloside
0.01 14.28 ± 0.91 2.42 ± 0.11c
0.05 11.96 ± 0.67c 1.92 ± 0.26
0.1 9.29 ± 0.58d 1.85 ± 0.22
0.5 7.73 ± 0.11d 1.63 ± 0.21
1 6.68 ± 0.24d 1.10 ± 0.12c
2,4-Dinitrophenol
5 14.23 ± 0.85 2.42 ± 0.06c
10 13.02 ± 0.64b 1.71 ± 0.10
50 11.86 ± 0.41c 0.80 ± 0.07d
Adenosine
100 26.52 ± 1.27d 0.64 ± 0.10d
1000 41.92 ± 1.55d 1.07 ± 0.12c
5000 n.d. 1.49 ± 0.17
Fatty acid biosynthesis was measured by [1-14C]acetate incorporation
into fatty acids. n.d.: not determined. Results are means ± S.D. of a
representative experiment. Mean value was signiﬁcantly diﬀerent from
control: aP < 0.05, bP < 0.02, cP < 0.01, dP < 0.001.
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trophenol, a well-known uncoupler of oxidative phosphoryla-
tion [14], gave similar results. On the other hand, addition of
adenosine, which expands the pool of adenine nucleotides
[15], resulted in a dose-dependent increase in ATP.
Table 1 also demonstrates the eﬀect of these compounds on
fatty acid biosynthesis in maintenance cultures of isolated he-
patocytes. The rate of fatty acid biosynthesis from glucose, as
monitored by incorporation of [1-14C]acetate, was stimulated
by cycloheximide in the micromolar range and inhibited by
the same compound in the millimolar range. Amytal, like cy-
cloheximide, increased the rate of synthesis at low concentra-
tions, whereas at higher levels it inhibited this process.
Atractyloside and 2,4-dinitrophenol showed similar biphasic
eﬀects. Adenosine displayed an opposite behaviour. It inhib-
ited the rate of fatty acid biosynthesis at low concentrations
whereas at higher levels this inhibition was partly relieved
again (Table 1).
It might be argued that in the experiments of Table 1 the
various added compounds alter in some way the speciﬁc radio-
activity of the intracellular acetyl-CoA pool, thereby seemingly
changing the rate of fatty acid biosynthesis. This possibility
was ruled out by performing control experiments using 3H2O
incorporation into fatty acids as an independent index of lipo-
genic activity [16]. The results obtained in these experiments
(Fig. 1) conﬁrm those obtained with the incorporation of
[1-14C]acetate (Table 1).A number of studies cf. [17] have indicated that ﬂuctuations
in the cellular level of cyclic 3 0–5 0-adenosine monophosphate
(cAMP) modulate the rate of fatty acid biosynthesis. In an at-
tempt to gain insight into the mechanism responsible for the
eﬀects shown in Table 1 and Fig. 1, the cellular concentration
of cAMP was determined under the conditions of these experi-
ments. As shown in Table 2, the eﬀects of cycloheximide, amy-
tal, atractyloside and 2,4-dinitrophenol on the rate of fatty
acid biosynthesis cannot be explained on the basis of varia-
tions in cAMP levels since addition of these compounds did
not signiﬁcantly change the cellular cAMP content. On the
other hand, addition of adenosine increased cAMP levels in
isolated liver cells (Table 2). Therefore, the eﬀect of this last
compound on the rate of fatty acid biosynthesis may be
related, at least in part, to the observed changes in cAMP
levels.4. Discussion
In this paper, the short-term eﬀect of the cellular concentra-
tion of ATP on the rate of de novo fatty acid biosynthesis in
isolated rat hepatocytes was studied. Four compounds were
used to lower the cellular ATP level. Their eﬀects on the rate
of fatty acid biosynthesis were similar. Low concentrations
of cycloheximide, amytal, atractyloside and 2,4-dinitrophenol
stimulated fatty acid biosynthesis in the isolated cell system
whereas higher concentrations of these compounds inhibited
this process.
The stimulatory eﬀect of a slight decrease in the cellular ATP
level on the rate of fatty acid biosynthesis, as evoked by low
concentrations of cycloheximide, amytal, atractyloside and
2,4-dinitrophenol, cannot be explained simply. At ﬁrst glance
it seems contradictory that decreases in the ATP level inversely
correlate with increases in the rate of fatty acid synthesis (Ta-
ble 1). It would seem that the opposite should prevail, i.e. a
surfeit of ATP should promote the synthesis of fat, the primary
storage form of energy. Indeed, several steps in the conversion
of glucose to fat require ATP, e.g. those catalysed by glucoki-
nase, 6-phosphofructo-1-kinase, pyruvate kinase, citrate clea-
vage enzyme and acetyl-CoA carboxylase. Even more
important, a decrease in ATP concentration should be ex-
pected to inhibit fatty acid biosynthesis because it would result
in an increase in AMP, which activates AMP-activated protein
kinase, which in turn inhibits acetyl-CoA carboxylase, the
most important regulatory enzyme of the pathway [18]. In-
deed, inhibition of acetyl-CoA carboxylase likely accounts
for the inhibition of fatty acid biosynthesis observed with the
lower cellular concentrations of ATP.
In spite of these considerations, a stimulation of fatty acid
biosynthesis combined with a modest lowering of the cellular
ATP level is a common denominator of the action of the four
compounds used in this study. At this point it should be
stressed that in our experiments only the ATP content of the
whole cell was measured. Since fatty acid biosynthesis occurs
in the cytosol, the ATP level in that compartment should be
the determining factor for the rate of this process. However,
over 70% of the cellular adenine nucleotides are found in the
cytosol [19]. Hence, changes in the cellular ATP concentration
are likely to be reﬂected in corresponding changes of the ATP
level in the cytosol. From the above considerations one is led
Fig. 1. The eﬀect of various compounds aﬀecting the cellular ATP concentration on fatty acid biosynthesis in maintenance cultures of isolated rat
hepatocytes as measured by the incorporation of 3H2O. Values for
3H2O-incorporation were converted to acetyl units by multiplying with 1.15 [16].
Results are means ± S.D. of a representative experiment. Mean value was signiﬁcantly diﬀerent from control: aP < 0.02, bP < 0.01, cP < 0.001. (A)
Cycloheximide; (B) amytal; (C) atractyloside; (D) 2,4-dinitrophenol; and (E) adenosine.
Table 2
Levels of cAMP in maintenance cultures of isolated rat hepatocytes
Additions (lM) cAMP (pmol/mg protein)
None 1.89 ± 0.11
Cycloheximide
50 1.77 ± 0.08
5000 1.87 ± 0.15
Amytal
0.1 1.78 ± 0.14
1000 1.95 ± 0.05
Atractyloside
0.01 1.97 ± 0.05
5 1.72 ± 0.22
2,4-Dinitrophenol
5 1.73 ± 0.10
50 1.74 ± 0.12
Adenosine
100 3.01 ± 0.17b
5000 2.65 ± 0.11a
Results are means ± S.D. of a representative experiment. Mean value
was signiﬁcantly diﬀerent from control: aP < 0.01. bP < 0.001.
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in the phosphorylation potential ([ATP]/[ADP] [Pi]) play a role
in the regulation of the rate of fatty acid biosynthesis and that
a small decrease in the concentration of ATP and/or phosphor-
ylation potential may stimulate this process. Perhaps the high
ATP concentration normally present in the cells is for somereasons impeding the rate of the process. In other words,
ADP is needed to convert glucose to fat. This is in line with
the notion that fatty acid synthesis from glucose is an en-
ergy-yielding process, producing 5 moles of ATP per mole of
palmitate formed as is shown in the following equation:
4.5glucose + 4O2 + 5ADP + 5Piﬁ palmitate + 11CO2 + 5ATP
[20,21]. In other words, the ATP-producing steps in the path-
way outweigh the ATP-requiring steps mentioned above. Inhi-
bition of the mitochondrial ATP production by the four
compounds used in this study increases the availability of
ADP and therefore promotes the substrate-level phosphoryla-
tion steps of aerobic glycolysis.
Adenosine was found to have an opposite, but also biphasic,
eﬀect on the rate of fatty acid biosynthesis (Table 1 and Fig. 1).
It inhibited especially at low concentrations. The inhibition
was partly relieved at higher concentrations. Inhibition of de
novo fatty acid biosynthesis by adenosine was also observed
by Harris and Yount [17]. Addition of adenosine increased
the cellular ATP level (Table 1; [22]) and inhibited the rate
of fatty acid biosynthesis. It is tempting to speculate that the
inhibition is a consequence of a large increase in the phosphor-
ylation potential ([ATP]/[ADP] [Pi]) caused by a marked in-
crease in [ATP] and depletion of the intracellular inorganic
phosphate pool during the conversion of adenosine to ATP.
It is likely that the magnitude of the phosphorylation potential
inhibits net synthesis of ATP that must occur during the con-
version of glucose to fat. However, a diﬀerent mechanism may
account for part of the results obtained with this compound.
Adenosine stimulates the formation of cAMP [17] (cf. Table
2), a compound known to inhibit fatty acid biosynthesis [17].
The unexpected ﬁnding of a biphasic eﬀect on fatty acid
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explained by the fact that hepatic adenylate cyclase shows an
inverse biphasic response to adenosine [23], most likely
because adenosine receptors that activate adenylate cyclase
are expressed in liver [24]. This is in line with the biphasic curve
seen for cAMP levels in the present report (Table 2).
The cycloheximide-induced lowering of the cellular ATP le-
vel was also observed by Blom et al. [5] who demonstrated that
this eventually led to apoptosis. Interestingly, these authors de-
monstrated that cycloheximide-induced apoptosis was blocked
by adenosine. This ﬁts nicely with the opposite eﬀects obtained
in the present study with cycloheximide and adenosine. Cyclo-
heximide-induced inhibition of fatty acid synthesis, i.e. the op-
posite of that reported here, is also documented in the
literature [25]. However, this is a long-term eﬀect resulting
from down regulation of lipogenic enzymes as a consequence
of inhibition of protein synthesis by cycloheximide. ATP inhi-
bition of fatty acid synthesis was reported previously by Rous
et al. [26] in studies carried out with liver homogenates. Their
ﬁndings, however, may not be relevant to the present study be-
cause synthesis of fatty acids under their conditions should
have consumed rather than produced ATP.
It is interesting to note that other well-established ATP-re-
quiring processes like glucose synthesis [27] and urea synthesis
[28] are reported to be stimulated by compounds that cause a
slight lowering of ATP. Based on the ﬁndings of the present
study, one could speculate that this stimulation is caused by
a release of the ATP impediment of the process in the control
condition. If the balanced equation could be written for the
overall process being measured, the process might be produ-
cing ATP rather than consuming ATP. The stimulation of urea
synthesis from proline [28] is likely explained by this mechan-
ism. Assuming concurrent synthesis of glucose from the
carbon of proline, ureagenesis from proline is an energy-yield-
ing process, producing 17 moles of ATP per mole of urea
formed as is shown in the following balanced equation:
2proline + 5O2 + 17ADP + 17Piﬁ 1urea + 1glucose + 3CO2 +
17ATP + 18H2O.
Other mechanisms that could have positive eﬀects upon fatty
acid synthesis, such as altered rates of production of reactive
oxygen species [29,30], cannot be ruled out by the data col-
lected in this study. Indeed, alternative explanations are possi-
ble for each of the compounds used in our experiments;
nevertheless, there seems to be only one common characteris-
tic, i.e. a slight increase in the rate of fatty acid synthesis in
response to amytal, cycloheximide, atractyloside and 2,4-dini-
trophenol coincides with a moderate drop in the cellular level
of ATP.
In conclusion, the results of the present study are in line with
the notion that fatty acid biosynthesis from glucose is an en-
ergy-yielding process and that a moderate drop in the cellular
ATP concentration triggers an increase in this process because
ADP is needed to convert glucose to fat. Conversely, excess
ATP can inhibit this process when the phosphorylation poten-
tial is too large for the conversion of glucose to fat. Further-
more, it is suggested that moderate ﬂuctuations in the
cytosolic ATP concentration play a role in the short-term reg-
ulation of fatty acid biosynthesis independent of the activity of
AMP-activated protein kinase.
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